News and Trends 31 Jan 2023
BiVictriX announces positive data from leukemia study
BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with BVX001, the company’s lead program,…
Clinical trial
- Latest Posts
News and Trends 27 Jan 2023
Psoriasis drug may help treat type 1 diabetes
A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on…
News and Trends 27 Jan 2023
Onxeo to study prostate cancer drug
French biotech company Onxeo S.A. has given an update on the clinical development program of its first-in-class drug candidate AsiDNA.…
News and Trends 27 Jan 2023
FDA clearance for ‘revolutionary’ approach to J-Pouch issue
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared its Investigational New Drug (IND)…
ADVERTISEMENT
News and Trends 26 Jan 2023
Orbsen Therapeutics happy with interim diabetic kidney disease study results
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the EU Horizon 2020-funded NEPHSTROM clinical…
Sponsored by LINK Medical
26 Jan 2023How clinical trials benefit from decentralized solutions: A Nordic case study
Digitization is changing the way clinical trials are conducted. Spurred by the pandemic, decentralized clinical trials are on the rise,…
News and Trends 26 Jan 2023
First patient treated in Atrogi type 2 diabetes clinical study
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been enrolled in a phase 1a/b…
News and Trends 24 Jan 2023
First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101, a T-cell progenitor cell injection…
News and Trends 20 Jan 2023
DeuterOncology closes financing round to start lung cancer study
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing, to start the phase I…
News and Trends 19 Jan 2023
Cloned maggot enzyme wound treatment moves closer to reality
Cambridge U.K. biotech company SolasCure, which is developing a wound cleaning technology, has published its pre-clinical results with the International…
News and Trends 19 Jan 2023
Avacta completes fourth dose escalation in tumor study
Avacta Group plc says that AVA6000 continues to show a favorable safety profile in the fourth dose cohort of the…
News and Trends 19 Jan 2023
GPCR Therapeutics launches multiple myeloma trial
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has started its phase 2 trial…
News and Trends 19 Jan 2023
Pathalys Pharma brings in $150M for SHPT trials
Pathalys Pharma, Inc. and Launch Therapeutics (Launch Tx) have announced a collaboration to advance phase 3 clinical trials for upacicalcet…
News and Trends 17 Jan 2023
Ascletis phase I COVID trial progressing
Ascletis Pharma Inc. has announced the dosing of four healthy subjects in its multiple-dose escalation phase I clinical trial of…
News and Trends 17 Jan 2023
EverImmune launches trial for oncobiotic lung and kidney cancer drug candidate
EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology, says…
News and Trends 12 Jan 2023
Breast cancer most studied disease area in 2022
Phesi, a global provider of patient-centric data analytics, has released the results of its global analysis of all clinical trials…
ADVERTISEMENT
News and Trends 11 Jan 2023
Renexxion goes to FDA with cystic fibrosis drug
Renexxion Ireland Limited has opened an investigational new drug (IND) application with the U.S Food and Drug Administration (FDA) for…
News and Trends 11 Jan 2023
What the new year holds for clinical research
Catherine Gregor is the chief clinical trial officer at Florence Healthcare. The company’s clinical trial software is used in more…
News and Trends 11 Jan 2023
Clinical trends for 2023
By Richard Staines, account director, Optimum Strategic Communications Few would deny that the decade has had a turbulent start, but…
News and Trends 9 Jan 2023
Selecta and Astellas sign LOPD treatment agreement
Selecta Biosciences, Inc. and Astellas Pharma Inc. have announced an exclusive licensing and development agreement for IdeXork (Xork). Xork is…
